Biofrontera BFRI
NASDAQ BFRI
$1.02 -0.06 (-5.50%)
As of: Oct 1, 2026 · 10:42 AM EDT

Biofrontera (BFRI) Raw Materials (2026)

Updated

Biofrontera's Raw Materials came in at $168,000 for Q2 2026.

Analysis

Biofrontera (BFRI) Raw Materials (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biofrontera 15.34 Mn -6.45 Mn 9.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168,000.00
API Access

Biofrontera Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=BFRI&period=max&api_key=YOUR_API_KEY